原发性中枢神经系统淋巴瘤的生物学亚型分类。
Sorting biologic subtypes of primary CNS lymphoma.
机构信息
National Cancer Institute.
出版信息
Blood. 2021 Mar 18;137(11):1436-1437. doi: 10.1182/blood.2020009968.
Abstract
In this issue of , Gandhi et al studied 91 cases of primary diffuse large B-cell lymphoma (DLBCL) of the central nervous system (CNS) (PCNSL) and compared the biologic features of tumors associated with Epstein-Barr virus (EBV) to tumors that are EBV using digital gene expression signatures and customized hybrid-capture targeted sequencing panels.
摘要
在本期 中，Gandhi 等人研究了 91 例原发性中枢神经系统弥漫性大 B 细胞淋巴瘤（PCNSL），并使用数字基因表达谱和定制的杂交捕获靶向测序面板比较了与 EBV 相关的肿瘤和 EBV 阳性肿瘤的生物学特征。
相似文献
1
Sorting biologic subtypes of primary CNS lymphoma.原发性中枢神经系统淋巴瘤的生物学亚型分类。
Blood. 2021 Mar 18;137(11):1436-1437. doi: 10.1182/blood.2020009968.
2
Controversies in primary CNS lymphoma.原发性中枢神经系统淋巴瘤的争议
Expert Rev Neurother. 2005 Jul;5(4):459-64. doi: 10.1586/14737175.5.4.459.
3
Pathology with clinical correlations of primary central nervous system non-Hodgkin's lymphoma. The Massachusetts General Hospital experience 1958-1989.原发性中枢神经系统非霍奇金淋巴瘤的病理学与临床相关性。麻省总医院1958 - 1989年的经验
Cancer. 1994 Aug 15;74(4):1383-97. doi: 10.1002/1097-0142(19940815)74:4<1383::aid-cncr2820740432>3.0.co;2-1.
4
Diagnosis and treatment of central nervous system involvement in non-Hodgkin's lymphoma.非霍奇金淋巴瘤中枢神经系统受累的诊断与治疗
Hematol Oncol Clin North Am. 2005 Aug;19(4):597-609, v. doi: 10.1016/j.hoc.2005.05.003.
5
New perspectives for patients with primary CNS lymphoma.原发性中枢神经系统淋巴瘤患者的新视角。
Radiother Oncol. 2017 Aug;124(2):331-332. doi: 10.1016/j.radonc.2017.04.027. Epub 2017 Jul 4.
6
Primary Central Nervous System Lymphoma-PART 1: Epidemiology, Diagnosis, Staging, and Prognosis.原发性中枢神经系统淋巴瘤——第1部分：流行病学、诊断、分期及预后
Oncology (Williston Park). 2018 Jan 15;32(1):17-22.
7
Primary central nervous system lymphoma: essential points in diagnosis and management.原发性中枢神经系统淋巴瘤：诊断与管理要点
Med Oncol. 2017 Apr;34(4):61. doi: 10.1007/s12032-017-0920-7. Epub 2017 Mar 17.
8
Primary CNS lymphoma: in search of the evidence.原发性中枢神经系统淋巴瘤：探寻证据
Lancet Haematol. 2015 Jun;2(6):e227-8. doi: 10.1016/S2352-3026(15)00091-5. Epub 2015 Jun 3.
9
Primary Central Nervous System Lymphoma-PART 2: Modern Therapeutic Management and Future Directions.原发性中枢神经系统淋巴瘤——第二部分：现代治疗管理与未来方向
Oncology (Williston Park). 2018 Feb 15;32(2):e11-e19.
10
Neurocognitive functions in primary CNS lymphoma.原发性中枢神经系统淋巴瘤中的神经认知功能
Neuro Oncol. 2021 Aug 2;23(8):1220-1221. doi: 10.1093/neuonc/noab113.
引用本文的文献
1
Clinical Characteristics, Prognostic Risk Factors, and Primary Treatment for Elderly Patients with Primary Central Nervous System Lymphoma: A Seer Database-Based Research.老年原发性中枢神经系统淋巴瘤患者的临床特征、预后危险因素及初始治疗：一项基于监测、流行病学和最终结果（SEER）数据库的研究
Blood Lymphat Cancer. 2025 Jul 7;15:85-101. doi: 10.2147/BLCTT.S529249. eCollection 2025.
2
Molecular diagnosis of vitreoretinal lymphoma.玻璃体视网膜淋巴瘤的分子诊断
Taiwan J Ophthalmol. 2024 Dec 24;15(2):236-244. doi: 10.4103/tjo.TJO-D-24-00052. eCollection 2025 Apr-Jun.
3
Phase 2 trial of ibrutinib and nivolumab in patients with relapsed CNS lymphomas.依鲁替尼与纳武单抗治疗复发中枢神经系统淋巴瘤患者的2期试验。
Blood Adv. 2025 Apr 8;9(7):1485-1491. doi: 10.1182/bloodadvances.2024014635.
4
Clinical outcomes of newly diagnosed primary central nervous system lymphoma treated with zanubrutinib-based combination therapy.采用泽布替尼联合疗法治疗新诊断的原发性中枢神经系统淋巴瘤的临床结果
World J Clin Oncol. 2023 Dec 24;14(12):606-619. doi: 10.5306/wjco.v14.i12.606.
5
Epstein-Barr virus as a leading cause of multiple sclerosis: mechanisms and implications.EB 病毒是多发性硬化症的主要病因：机制和意义。
Nat Rev Neurol. 2023 Mar;19(3):160-171. doi: 10.1038/s41582-023-00775-5. Epub 2023 Feb 9.
6
Altered Immune Response to the Epstein-Barr Virus as a Prerequisite for Multiple Sclerosis.改变的对 Epstein-Barr 病毒的免疫反应是多发性硬化症的前提。
Cells. 2022 Sep 4;11(17):2757. doi: 10.3390/cells11172757.
7
The PI3K/AKT/mTOR signaling pathway is aberrantly activated in primary central nervous system lymphoma and correlated with a poor prognosis.PI3K/AKT/mTOR 信号通路在原发性中枢神经系统淋巴瘤中异常激活，并与不良预后相关。
BMC Cancer. 2022 Feb 20;22(1):190. doi: 10.1186/s12885-022-09275-z.
8
Epstein Barr Virus Exploits Genetic Susceptibility to Increase Multiple Sclerosis Risk.爱泼斯坦-巴尔病毒利用基因易感性增加多发性硬化症风险。
Microorganisms. 2021 Oct 21;9(11):2191. doi: 10.3390/microorganisms9112191.
本文引用的文献
1
EBV-associated primary CNS lymphoma occurring after immunosuppression is a distinct immunobiological entity.发生于免疫抑制后的 EBV 相关原发性中枢神经系统淋巴瘤是一种独特的免疫生物学实体。
Blood. 2021 Mar 18;137(11):1468-1477. doi: 10.1182/blood.2020008520.
2
A Probabilistic Classification Tool for Genetic Subtypes of Diffuse Large B Cell Lymphoma with Therapeutic Implications.具有治疗意义的弥漫性大 B 细胞淋巴瘤遗传亚型的概率分类工具。
Cancer Cell. 2020 Apr 13;37(4):551-568.e14. doi: 10.1016/j.ccell.2020.03.015.
3
Tisagenlecleucel CAR T-cell therapy in secondary CNS lymphoma.tisagenlecleucel CAR T 细胞疗法治疗中枢神经系统淋巴瘤。
Blood. 2019 Sep 12;134(11):860-866. doi: 10.1182/blood.2019001694. Epub 2019 Jul 18.
4
Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes.弥漫性大 B 细胞淋巴瘤的分子亚型与不同的发病机制和预后相关。
Nat Med. 2018 May;24(5):679-690. doi: 10.1038/s41591-018-0016-8. Epub 2018 Apr 30.
5
How I treat T-cell chronic active Epstein-Barr virus disease.我如何治疗 T 细胞慢性活动性 EBV 病。
Blood. 2018 Jun 28;131(26):2899-2905. doi: 10.1182/blood-2018-03-785931. Epub 2018 Apr 30.
6
Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma.弥漫性大B细胞淋巴瘤的遗传学与发病机制
N Engl J Med. 2018 Apr 12;378(15):1396-1407. doi: 10.1056/NEJMoa1801445.
7
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling.通过基因表达谱鉴定出的不同类型弥漫性大B细胞淋巴瘤。
Nature. 2000 Feb 3;403(6769):503-11. doi: 10.1038/35000501.
Zotero 插件